Linzess is a Oral Capsule, Gelatin Coated in the Human Prescription Drug category. It is labeled and distributed by Allergan, Inc.. The primary component is Linaclotide.
| Product ID | 0456-1201_114152bc-d286-4228-9b01-9814473d3875 | 
| NDC | 0456-1201 | 
| Product Type | Human Prescription Drug | 
| Proprietary Name | Linzess | 
| Generic Name | Linaclotide | 
| Dosage Form | Capsule, Gelatin Coated | 
| Route of Administration | ORAL | 
| Marketing Start Date | 2012-09-08 | 
| Marketing Category | NDA / NDA | 
| Application Number | NDA202811 | 
| Labeler Name | Allergan, Inc. | 
| Substance Name | LINACLOTIDE | 
| Active Ingredient Strength | 145 ug/1 | 
| Pharm Classes | Guanylate Cyclase-C Agonist [EPC],Guanylate Cyclase Activators [MoA] | 
| NDC Exclude Flag | N | 
| Listing Certified Through | 2020-12-31 | 
| Marketing Start Date | 2012-09-08 | 
| NDC Exclude Flag | N | 
| Sample Package? | N | 
| Marketing Category | NDA | 
| Application Number | NDA202811 | 
| Product Type | HUMAN PRESCRIPTION DRUG | 
| Marketing Start Date | 2012-09-08 | 
| Marketing Category | NDA | 
| Application Number | NDA202811 | 
| Product Type | HUMAN PRESCRIPTION DRUG | 
| Billing Unit | EA | 
| Marketing Start Date | 2012-09-08 | 
| Ingredient | Strength | 
|---|---|
| LINACLOTIDE | 145 ug/1 | 
| SPL SET ID: | 09beda19-56d6-4a56-afdc-9a77b70b2ef3 | 
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI | |
| UPC Code | 
| NDC | Brand Name | Generic Name | 
|---|---|---|
| 0456-1201 | Linzess | linaclotide | 
| 0456-1202 | Linzess | linaclotide | 
| 0456-1203 | Linzess | linaclotide | 
| Mark Image Registration | Serial | Company Trademark Application Date | 
|---|---|
|  LINZESS  85773175  4614364 Live/Registered | Ironwood Pharmaceuticals, Inc. 2012-11-06 | 
|  LINZESS  77872111  4328588 Live/Registered | Ironwood Pharmaceuticals, Inc. 2009-11-13 |